Oncodesign Precision Medicine (XPAR:ALOPM) EV-to-FCF : (As of Apr. 09, 2025)

Oncodesign Precision Medicine EV-to-FCF Chart

Competitive Comparison of Oncodesign Precision Medicine's EV-to-FCF

For the Biotechnology subindustry, Oncodesign Precision Medicine's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncodesign Precision Medicine's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncodesign Precision Medicine's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Oncodesign Precision Medicine's EV-to-FCF falls into.

Oncodesign Precision Medicine EV-to-FCF Calculation

Oncodesign Precision Medicine's EV-to-FCF for today is calculated as:

Oncodesign Precision Medicine's current Enterprise Value is €6.21 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Oncodesign Precision Medicine's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncodesign Precision Medicine  (XPAR:ALOPM) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Oncodesign Precision Medicine's PE Ratio (TTM) for today is calculated as:

Oncodesign Precision Medicine's share price for today is €0.425.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Oncodesign Precision Medicine's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.447.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Oncodesign Precision Medicine EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncodesign Precision Medicine Business Description